Published in Eur J Clin Microbiol Infect Dis on February 01, 1990
Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev (1994) 5.77
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev (2010) 4.76
Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. J Bacteriol (1997) 4.52
Current perspectives on glycopeptide resistance. Clin Microbiol Rev (1995) 2.99
Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother (2003) 2.80
Outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian hospital. J Clin Microbiol (2000) 1.33
Protein binding and serum bactericidal activities of vancomycin and teicoplanin. Antimicrob Agents Chemother (1995) 1.09
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China. Antimicrob Agents Chemother (2009) 1.03
Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program. Antimicrob Agents Chemother (1994) 0.91
Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity. Antimicrob Agents Chemother (1991) 0.90
Vancomycin sensitivity of Staphylococcus aureus isolates from hospital patients in Karachi, Pakistan. Libyan J Med (2007) 0.78
Successful treatment of right-sided prosthetic valve endocarditis due to methicillin-resistant teicoplanin-heteroresistant Staphylococcus aureus with linezolid. Eur J Clin Microbiol Infect Dis (2005) 0.76
Iatrogenic complications in adult intensive care units: a prospective two-center study. Crit Care Med (1993) 2.84
Nucleotide sequences of the genes coding for the TEM-like beta-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2). FEMS Microbiol Lett (1994) 2.24
Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine? Leuk Res (2011) 2.23
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias. Leukemia (2011) 2.12
STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood (1996) 1.99
Molecular identification of the role of voltage-gated K+ channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes. J Clin Invest (1998) 1.92
Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms. Leukemia (2010) 1.75
Silene as a model system in ecology and evolution. Heredity (Edinb) (2009) 1.68
Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N Engl J Med (1995) 1.67
Assessing the performance of single-copy genes for recovering robust phylogenies. Syst Biol (2008) 1.66
High genetic diversity in French invasive populations of common ragweed, Ambrosia artemisiifolia, as a result of multiple sources of introduction. Mol Ecol (2005) 1.64
Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas. Leukemia (2004) 1.62
Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 NEF protein. J Immunol (1991) 1.60
hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG. Oncogene (1998) 1.57
PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML. Leukemia (2008) 1.55
Negative catheter-tip culture and diagnosis of catheter-related bacteremia. Nutrition (1995) 1.52
Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial. J Clin Oncol (1995) 1.48
Qualitative and quantitative analysis of human cytotoxic T-lymphocyte responses to HIV-1 proteins. AIDS (1992) 1.47
Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation (1987) 1.44
Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM). Bone Marrow Transplant (2000) 1.44
Mutation in RAP1 is a rare event in myelodysplastic syndromes. Leukemia (2005) 1.44
An antigenic peptide of the HIV-1 NEF protein recognized by cytotoxic T lymphocytes of seropositive individuals in association with different HLA-B molecules. Eur J Immunol (1989) 1.43
Activity of the caspase-3/CPP32 enzyme is increased in "early stage" myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro. Exp Hematol (2000) 1.43
[Plasmid resistance to 3d generation cephalosporins]. Presse Med (1988) 1.41
Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation. J Clin Oncol (2000) 1.39
SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications. Leukemia (2011) 1.38
The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia. Leukemia (2011) 1.37
Cospeciation vs host-shift speciation: methods for testing, evidence from natural associations and relation to coevolution. New Phytol (2013) 1.33
Sex, outcrossing and mating types: unsolved questions in fungi and beyond. J Evol Biol (2012) 1.22
Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias. Lancet (1987) 1.22
Pathogen relatedness affects the prevalence of within-host competition. Am Nat (2006) 1.08
High-dose darbepoetin alpha in the treatment of anaemia of lower risk myelodysplastic syndrome results of a phase II study. Br J Haematol (2006) 1.07
Bedside evaluation of right ventricular performance using a rapid computerized thermodilution method. Crit Care Med (1987) 1.06
When can host shifts produce congruent host and parasite phylogenies? A simulation approach. J Evol Biol (2007) 1.06
Evi-1 expression in leukemic patients with rearrangements of the 3q25-q28 chromosomal region. Leukemia (1992) 1.03
Acute-phase response, interleukin-6, and alteration of cyclosporine pharmacokinetics. Clin Pharmacol Ther (1994) 1.01
A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse. Leukemia (2013) 1.01
Is intensive care justified for patients with haematological malignancies? Intensive Care Med (1990) 0.99
[Septic arthritis caused by Campylobacter fetus]. Rev Rhum Mal Osteoartic (1986) 0.97
Fludarabine plus cyclophosphamide in Waldenström's macroglobulinemia: results in 49 patients. Leukemia (2005) 0.97
High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients. Blood (1993) 0.96
[Bacterial flora in gastric juice taken at endoscopy in 93 normal subjects]. Pathol Biol (Paris) (1986) 0.96
Sympatric genetic differentiation of a generalist pathogenic fungus, Botrytis cinerea, on two different host plants, grapevine and bramble. J Evol Biol (2007) 0.96
The anther smut disease on Gypsophila repens: a case of parasite sub-optimal performance following a recent host shift? J Evol Biol (2005) 0.96
[Cardiac localization of non Hodgkin's lymphoma: a study on four cases]. Rev Med Interne (2003) 0.96
Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes. Leukemia (1997) 0.96
Two Sibling Species of the Botrytis cinerea Complex, transposa and vacuma, Are Found in Sympatry on Numerous Host Plants. Phytopathology (1999) 0.96
Treatment of myelodysplastic syndromes with 5q deletion before the lenalidomide era; the GFM experience with EPO and thalidomide. Leuk Res (2008) 0.95
Postglacial recolonization history of the European crabapple (Malus sylvestris Mill.), a wild contributor to the domesticated apple. Mol Ecol (2013) 0.95
Value of elementary, combined, and modeled hemodynamic variables. J Crit Care (1994) 0.94
Phylogenetic determinants of potential host shifts in fungal pathogens. J Evol Biol (2009) 0.94
Sex in Penicillium: combined phylogenetic and experimental approaches. Fungal Genet Biol (2010) 0.94
Existence of a pattern of reproductive character displacement in Homobasidiomycota but not in Ascomycota. J Evol Biol (2008) 0.93
Maximized virulence in a sterilizing pathogen: the anther-smut fungus and its co-evolved hosts. J Evol Biol (2008) 0.91
Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes. Leukemia (2013) 0.91
Intensified-dose (4 gm/m2) cyclophosphamide and granulocyte colony-stimulating factor administration for hematopoietic stem cell mobilization in refractory rheumatoid arthritis. Arthritis Rheum (1999) 0.90
Mechanisms of decreased left ventricular preload during continuous positive pressure ventilation in ARDS. Chest (1986) 0.90
Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS. Leuk Res (2011) 0.90
A G polymorphism in the CRBN gene acts as a biomarker of response to treatment with lenalidomide in low/int-1 risk MDS without del(5q). Leukemia (2013) 0.90
In-vitro activity of cephalosporins alone and combined with sulbactam against various strains of Acinetobacter baumannii with different antibiotic resistance profiles. J Antimicrob Chemother (1996) 0.89
The population biology of fungal invasions. Mol Ecol (2015) 0.89
Molecular detection of t(8;21)/AML1-ETO in AML M1/M2: correlation with cytogenetics, morphology and immunophenotype. Br J Haematol (1996) 0.89
Erythroleukemia: a need for a new definition. Leukemia (2002) 0.88
Constitutive phosphoinositide 3-kinase activation in acute myeloid leukemia is not due to p110delta mutations. Leukemia (2006) 0.88
High-dose therapy and autologous blood stem cell transplantation in multiple myeloma: preliminary results of a randomized trial involving 167 patients. Stem Cells (1995) 0.88
Erythroleukaemia and RAEB-t: a same disease? Leukemia (2004) 0.87
Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty. The ACCORD Study. Angioplastic Coronaire Corvasal Diltiazem. Circulation (1997) 0.87
Migration patterns and changes in population biology associated with the worldwide spread of the oilseed rape pathogen Leptosphaeria maculans. Mol Ecol (2012) 0.86
Tuberculosis due to Mycobacterium bovis after alemtuzumab administration. Clin Infect Dis (2003) 0.86
Evolution of uni- and bifactorial sexual compatibility systems in fungi. Heredity (Edinb) (2013) 0.86
Autoimmune haemolytic anaemia revealing miliary tuberculosis. J Infect (2000) 0.85
Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine. Leukemia (2011) 0.85
Fulminant Pneumocystis carinii pneumonia in 4 patients with dermatomyositis. Arch Intern Med (1997) 0.85
Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AML. Leukemia (2012) 0.85
Hemodialysis for acute renal failure in patients with hematologic malignancies. Crit Care Med (1991) 0.85
Right ventricular dysfunction in patients with septic shock. Intensive Care Med (1988) 0.85
Therapy-related acute myeloid leukaemia after successful therapy for acute promyelocytic leukaemia with t(15;17): a report of two cases and a review of the literature. Br J Haematol (2000) 0.85
Hybrid sterility and inviability in the parasitic fungal species complex Microbotryum. J Evol Biol (2009) 0.84
Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study. Br J Haematol (1998) 0.84
[Septicemia due to Salmonella wien. Diagnostic, therapeutic and epidemiologic problems]. Ann Med Interne (Paris) (1974) 0.84
Sibling competition arena: selfing and a competition arena can combine to constitute a barrier to gene flow in sympatry. Evolution (2012) 0.84
In-vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative staphylococci. J Antimicrob Chemother (1996) 0.83
Expression of the c-mpl proto-oncogene in human hematologic malignancies. Blood (1993) 0.83
Finding candidate genes under positive selection in Non-model species: examples of genes involved in host specialization in pathogens. Mol Ecol (2009) 0.83
Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 cases. Leukemia (2009) 0.83
Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases. J Hepatol (2000) 0.83
Thrombopoietin activates human platelets and induces tyrosine phosphorylation of p80/85 cortactin. Thromb Haemost (1998) 0.83
Relationship between changes in serum estrone levels and outcome in human males with septic shock. Circ Shock (1992) 0.83